Under the weight loss drug craze, stock prices are soaring! Billionaire investor: Lilly will become the first trillion dollar pharmaceutical company in history
芊芊551
发表于 2023-12-14 10:58:12
275
0
0
With the global popularity of "weight loss pills", the stock price of American pharmaceutical giant Eli Lilly has recently reached a historic high. In the eyes of billionaire investor and co-founder of Home Depot, Ken Langone, Eli Lilly's stock price prospects are bright, with the potential to become the first pharmaceutical company in history worth over a trillion dollars.
"I think Lilly will become the first pharmaceutical company in history worth trillions of dollars," Langney said in a media interview on Wednesday. "Why? Because of their research and development pipeline. May God bless (former CEO) John Lehrett. In the dark years when everything fell off a cliff, he was firmly committed to using funds for research and development and maintaining dividends."
Langney stated that the bright future of Lilly is closely related to the previous leadership of Lehlet. "He said, 'We won't cut research and development funds, we will focus our efforts to ensure that our investments receive greater returns. They did it.'"
Langny has always been a long-term shareholder of Lilly, and on Wednesday he stated that as early as 2015, Lilly had been his preferred stock. "In the 46 years I held it, including dividends, the compound annual growth rate of (the stock) reached 14.8%," he said.
The stock price surged by over 60% this year
Since this year, GLP-1 weight-loss drugs have become popular all over the world. With Mounjaro, a diabetes medicine, and Zepbound, a weight-loss drug, Lilly's share price has soared by nearly 64%, becoming one of the biggest winners of the global craze for weight-loss drugs.
Earlier this month, Lilly announced that its weight loss drug Zepbound had been launched in American pharmacies and was suitable for adults who are overly obese. The main component of Zepbund is telposide, which works by mimicking hormones, stimulating insulin release, increasing satiety, and reducing appetite. Since 2022, Lilly's Tilporide has been marketed as a drug Mounjaro for the treatment of type 2 diabetes.
In May of this year, Lilly surpassed Johnson&Johnson to become the world's largest pharmaceutical company by market value. The current market value of Lilly is approximately $567.2 billion, with more than 76% room for growth compared to the trillion dollar market value expected by Langney.
At the same time, the stock price of Danish pharmaceutical giant Novo Nordisk has surged with GLP-1 drugs such as Ozempic, and the stock has risen nearly 45% so far this year.
In stark contrast to the endless glory of Lilly and Novo Nordisk, some other pharmaceutical stocks are struggling.
Taking Pfizer as an example, the company's stock price has fallen by nearly 50% so far this year. On Wednesday, Pfizer's stock price fell after predicting that its 2024 sales may be $5 billion lower than Wall Street's expectations as revenue from COVID-19 vaccines and treatments continued to slow.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Over the past year, it has skyrocketed nearly 7 times! Can Nvidia's soaring stock price continue?
- Bitcoin once broke through $64000 in the cryptocurrency market, with over 110000 people selling out in 24 hours
- Up 96.92%! This Chinese concept brokerage stock is soaring
- Baidu Vice President Xie Guangjun: 2024 will become the first year of the explosion of domestic large-scale model industry applications
- One bottle of heavyweight new drug approved for 100000 yuan! How much impact will the soaring stock price have?
- The price reduction is effective! Apple's "Big Counterattack" on Sales in China and "Greatest Price Reduction in History" have Initiated
- NetEase Youdao CEO Zhou Feng: Integration of production and modeling will become a trend. Super App may be born at any time | Financial Interview
- Missing Nvidia's frenzy perfectly, losing $1.2 billion in "blood loss"? Sister Mu still insists that the valuation is too high!
- Apple will become the first tech giant to face accusations of new EU digital laws
- Illustration: How did the stock, bond, and foreign exchange markets perform after the Federal Reserve cut interest rates in history?
-
随着“银十”结束,各家造车新势力都交出了一份亮眼的成绩单。 理想领跑10月新势力交付榜,鸿蒙智行重回4万辆,零跑、深蓝、极氪、小鹏等单月交付量均创新高,岚图、阿维塔、智己等实现破万,但哪吒却消失在 ...
- fanadam
- 半小时前
- 支持
- 反对
- 回复
- 收藏
-
【科技记者古尔曼:苹果计划于12月第一周发布iOS 18.2系统更新 带来更多人工智能功能】科技记者古尔曼透露,苹果计划于12月第一周发布iOS 18.2系统更新。iOS 18.2将为iPhone 15 Pro机型和所有iPhone 16机型带来更多 ...
- cristianna
- 昨天 17:32
- 支持
- 反对
- 回复
- 收藏
-
为期超七周的大罢工终于落下帷幕。 当地时间11月4日,波音美国西海岸工厂工人们就改进后的合同提案投票。 随后,代表着波音超过33000名西雅图地区机械师的IAM工会经表决,以59%的同意票决定接纳波音提 ...
- cristianna
- 3 小时前
- 支持
- 反对
- 回复
- 收藏
-
近日,爱立信中国区总裁方迎在接受《经济参考报》记者采访时表示,5G技术在全球范围内得到了迅速发展,但面临商业潜力未能充分挖掘、网络运营难度较以往更高两大挑战。因此,运营商在继续5G网络部署的同时,应关 ...
- blueskybb
- 昨天 15:05
- 支持
- 反对
- 回复
- 收藏